Next Article in Journal
Reactive Stroma as a Transversal Prognostic Biomarker for Metastasis in Breast Cancer: Integration of Digital Histopathology and Transcriptomic Profiling
Next Article in Special Issue
Accomplishments of “Old-Fashioned” Electron Microscopy in the Period of Dominance of Immunofluorescent Methods
Previous Article in Journal
Th2 Cytokines Reshape the Transcriptome: Insights from a Canine Organoid Model of Atopic Dermatitis
Previous Article in Special Issue
Ultrastructural Features, Immune Response, and Junctional Proteins in the Seminiferous Epithelium of SARS-CoV-2-Infected Mice
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Ultrastructural Study of the Effects of Hybrid Compounds of Natural Monoterpene Carvacrol and Synthetic Cationic Amphiphile DL412 on S. aureus and E. faecalis Cells

by
Elena S. Ryabova
,
Alina E. Grigor’eva
,
Alevtina V. Bardasheva
,
Anastasiya V. Tupitsyna
,
Danila A. Zadvornykh
,
Lyudmila S. Koroleva
and
Elena I. Ryabchikova
*
Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of Russian Academy of Science, Lavrent’ev av., 8, Novosibirsk 630090, Russia
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2026, 27(5), 2217; https://doi.org/10.3390/ijms27052217
Submission received: 28 January 2026 / Revised: 25 February 2026 / Accepted: 25 February 2026 / Published: 26 February 2026

Abstract

Ultrastructure changes in S. aureus and E. faecalis bacteria incubated with synthetic cationic amphiphile DL412 and its hybrids with the natural monoterpene carvacrol were studied. The hybrid compounds DL4CAR-6, DL5CAR-6, DLpCAR-6, and DLoCAR-6 contained two carvacrol molecules and differed in central linker structure. The study was conducted on ultrathin sections of bacteria fixed by the Ryter–Kellenberger method and on a Jem 1400 transmission electron microscope (Jeol, Tokyo, Japan). Ultrastructure changes in S. aureus and E. faecalis incubated with compound DL412 were species-specific. Destructive changes in S. aureus cells when exposed to DL412 compound and all DL412-carvacrol hybrids did not differ. DL412 and DL412-carvacrol hybrids in E. faecalis cells damaged all structures except the cell wall. Compound DL412 and its hybrids disrupted the ultrastructure of nucleoid and DNA strands in both bacterial species. Complete disorganization of ribosomes in cells of both bacteria occurred upon incubation with compound DL412 and its carvacrol-bearing analog DL4CAR-6. Inclusions in bacterial cells exposed to all compounds had the same ultrastructure. The study showed that all compounds used possess multitarget properties; the structure of the central linker of hybrid compounds plays a significant role in the nature of their damaging effect on S. aureus and E. faecalis cells.

Graphical Abstract

1. Introduction

Growing bacterial resistance to clinically used antibacterial compounds (ABCs) is a global health problem. The development and implementation of new antibiotics into practice is not keeping pace with the rate of resistance mechanisms development in bacteria, which is why there is an increasing demand for new antibiotics [1,2]. The World Health Organization (WHO) has established four criteria for innovation, namely: a new ABC (i) must be from a new class of chemicals, (ii) have a new target, (iii) have a new mechanism of action and (iv) be free from cross-resistance to existing antibiotics [3].
Heimann D. and colleagues published in 2025 an analysis of seventy ABCs, based on fundamentally new chemical compounds that are currently in various stages of clinical trials [4]. More than two-thirds of these compounds were aimed at disrupting the function of a single target, primarily a specific protein. However, point mutations in bacterial DNA quickly alter the structure of the target protein, which reduces the affinity of the antibiotic for it and, accordingly, reduces the effectiveness of drugs acting on a single target. Therefore, multitargeted ABCs directed at non-proteogenic targets, such as RNA and lipids, are coming to the fore [4]. Multitarget ABCs contain two or more pharmacophore groups, which are combined into a single molecule using a linker, which ensures action on several targets in the bacterial cell. The effectiveness of multitargeted compounds against antibiotic-resistant bacteria is undeniable, but their development is not active. According to a review [4], only one in 70 compounds has two targets, and another is a mixture of two compounds directed at different targets.
Previously, we proposed compounds based on quaternary salts of 1,4-diazabicyclo [2.2.2]octane (DABCO) with the general structure shown in Figure 1A as multitarget ABCs. These compounds, according to their chemical structure, belong to cationic amphiphiles, one example of which is antimicrobial peptides, the antibacterial properties of which have been described in the published literature [5,6,7].
Cationic amphiphiles are believed to be capable of causing disruption of the transmembrane potential, leakage of cytoplasmic contents, and, ultimately, cell death [8]. We previously showed that DABCO-based cationic amphiphiles possess RNA hydrolyzing activity in vitro [9]. It could be assumed that after penetrating the cell membrane, these compounds would affect bacterial RNA.
The structure of the central linker can potentially influence the antibacterial properties of cationic amphiphiles, and we have previously studied this influence. Thus, it was shown that the length of the central linker of 4–6 carbon atoms ensures maximum activity of RNA hydrolysis by cationic amphiphilic compounds based on DABCO [10,11]. Antibacterial activity also showed a bell-shaped dependence on the length of the hydrophobic residue (alkyl chain), with the highest activity observed in compounds containing alkyl chains with 10–12 carbon atoms [12].
A study of the antibacterial activity of the synthesized cationic amphiphiles showed that the most effective compound against a number of Gram-positive and Gram-negative microorganisms was DL412 [12]. The name of the compound reflects its structure: D—DABCO, L4—tetramethylene linker, 12—dodecyl residue, Figure 1A. We revealed a clear multitarget effect of compound DL412 on Salmonella enterica and Staphylococcus aureus using transmission electron microscopy (TEM): the ultrastructure of the cell envelope, ribosomes and nucleoid of bacteria was disrupted [13,14].
The cationic amphiphile DL412 has two hydrophobic tails that may be replaced by compounds with known antibacterial activity, which may lead to a stronger final hybrid. We implemented this approach by incorporating the antibiotic ciprofloxacin into the structure of a DABCO-based cationic amphiphile. (Figure 1B) [15]. To understand the mechanisms of hybrid structure action, we conducted a comparative study of the effects of the antibiotic ciprofloxacin, a cationic amphiphile DL412, and the hybrid structure on S. aureus using TEM. The effect of the hybrid structure on S. aureus, although combining the effects of ciprofloxacin and the cationic amphiphile, was not their simple sum [13].
The next step in the development of hybrid compounds is this study, which examined the damaging effects of new cationic amphiphile compounds based on DABCO and the natural monoterpene carvacrol (Figure 1C).
Carvacrol, a component of many natural essential oils, has demonstrated potent damaging activity against a variety of bacteria and fungi. Physicochemical studies of carvacrol’s action have revealed membrane depolarization, potassium and phosphate leakage, increased membrane permeability, and inhibition of cellular respiration [16,17,18,19,20]. Obviously, changes in physiological parameters inevitably lead to disruption of bacterial cell structure. However, only two TEM studies of S. aureus have been published, describing cytoplasmic coagulation, the formation of mesosome-like structures, membrane damage, and the “release” of cellular contents [20,21,22].
It was clear to us that the described effects of carvacrol were due to its action as a single molecule, whereas incorporation into a compound could “neutralize” its effects. Nevertheless, carvacrol’s impressive array of activities prompted us to select it as a component of the DABCO-based hybrid compound.
In this work, we investigated the ultrastructural changes induced by the hybrid compounds DABCO and carvacrol in the cells of two Gram-positive bacteria. The Staphylococcus aureus and Enterococcus faecalis used in our work are known as causative agents of many human diseases [23,24], and S. aureus is included in the WHO List of Priority Bacterial Pathogens [25].

2. Results

2.1. Ultrastructure of S. aureus and E. faecalis Intact Cells

Intact cells of S. aureus and E. faecalis were round cocci measuring 500–600 nm in size with a fairly high electron density (Figure 2A,D). The cells were actively dividing; in sections, almost half of the cells had a division septum. Dividing cells of E. faecalis had a characteristic ovoid shape, and the cell wall formed angles near the division septum (Figure 2D).
The cell envelope of both bacterial species consisted of a cell wall, which was a thick layer of peptide glycans in the form of a thin fibrous material of medium electron density, and an underlying cytoplasmic membrane. The ultrastructure of the membranes of both species was visible as a thin, low-density band only in some areas; it was generally indistinguishable in sections (Figure 2C,F). The intermediate layer between the cell wall and cytoplasmic membrane was composed of electron-dense “grains” (1–2 nm).
The fixation technique we used allowed us to identify differences in the cell wall structure of the bacteria studied. The cell wall of S. aureus (25–30 nm) had a smooth surface or was covered with a “fur” of short filaments; three layers were recognized within the wall: the outer layer and the membrane-adjacent layer had a higher electron density than the layer located between them (Figure 2C). The cell wall of E. faecalis (20–25) nm had a smooth surface and was composed of homogeneous material of medium or low electron density (Figure 2F).
The cell cytoplasm was granular with medium to high electron density in both bacterial species. In the cytoplasm of S. aureus cells, rare small (5–10 nm) particles of high electron density were observed, which might be individual ribosome subunits (Figure 2C). The cytoplasm ultrastructure of S. aureus and its electron density were the same throughout the cell. In E. faecalis cells, the cytoplasm was composed of two zones (layers): a wide outer zone filled with spherical particles (10–12 nm) with medium electron density, and a narrow zone around the nucleoid composed of homogeneous material of lower electron density than the rest of the cytoplasm (Figure 2D).
The nucleoid in S. aureus and E. faecalis cells was represented by a single fragment of irregular shape, usually located in the center of the cell (never touching the membrane) (Figure 2A,D). The nucleoid in S. aureus cells was seen as a zone of granular material of the average electron density, in which DNA strands were sometimes visible, while in E. faecalis, nucleoid DNA strands were seen more clearly. In the S. aureus nucleoid, the “blurred” DNA strands were uniformly distributed without any visible sign of organization (Figure 2B). In contrast, in the E. faecalis nucleoid, the DNA strands were more distinct, had a higher electron density, and were organized into bundles of varying morphology (Figure 2E).
Thus, intact cells of S. aureus and E. faecalis had the same set of cellular structures, but differed in subtle details, and this led to a different visual appearance of the cells.

2.2. S. aureus and E. faecalis Ultrastructure Alteration by DL412

Exposure of S. aureus cells to DL412 resulted in damage to the ultrastructure of the cell wall, cytoplasmic membrane, cytoplasm and nucleoid. In contrast, the cell wall of E. faecalis cells retained the structure observed in intact cells; however, the cytoplasmic membrane, cytoplasm, and nucleoid of the bacterium cells were damaged (Figure 3).
Interaction of DL412 with the S. aureus envelope led to significant loosening of the cell wall and its detachment from the cytoplasmic membrane surface; the electron density of the intermediate layer decreased (Figure 3A,C). A distortion of the division septum was noted in most dividing S. aureus cells. Penetration of the DL412 compound into E. faecalis cells did not cause visible changes in the cell wall; however, the intermediate layer was altered; it was not visible in sections or was seen as fragmented.
The cytoplasmic membrane of both bacterial species was observed over the entire surface of cells incubated with the DL412 compound (Figure 3C,F), whereas in intact cells, the membrane was poorly visualized. In some areas, the cytoplasmic membrane was replaced by layered electron-dense inclusions with clear boundaries (Figure 3), in the thickness of which layers (5–6 nm) were distinguished. The inclusions gradually increased in size and penetrated deeper into the cell, their shape approached roundness, and the material became homogeneous, starting from the center; finally, spherical homogeneous inclusions were visible on sections (Figure 3G–J). Apparently, the formation of the inclusions was the result of the interaction of the DL412 compound that had penetrated into the cells with cellular components. The structure of inclusions did not differ in cells of S. aureus and E. faecalis.
Incubation of S. aureus cells with DL412 caused “disappearance” of ribosomes; the cytoplasm was uniformly fine-grained (Figure 3C). In E. faecalis cells, visible ribosomes were deformed and partially aggregated; they acquired an irregular shape and stuck together to form particles 20–25 nm in size (Figure 3F). The cells of E. faecalis lost the ribosome-free zone around the nucleoid, and ribosome aggregates were found right up to the borders of the nucleoid (Figure 3D,F).
The nucleoid structure in S. aureus cells varied when incubated with DL412, apparently reflecting its disorganization. Instead of a single nucleoid, several fragments were observed in sections, some of which were displaced toward the cytoplasmic membrane (Figure 3A,B). The nucleoid’s “filling” material became electron-transparent, and DNA strands were better seen against this background; signs of structural organization of DNA strands were not detected (Figure 3B).
The nucleoid of E. faecalis cells acquired a roundish shape when cells were incubated with DL412 (Figure 3D–F). The DNA strands were organized into bundles and had very clear outlines (Figure 3E). In some areas, homogeneous material with average electron density was detected between the strands, which may be the result of DNA strand fraying.

2.3. S. aureus Ultrastructure Alteration by DL4CAR-6, DL5CAR-6, DLpCAR-6 and DLoCAR-6 Compounds

The ultrastructure of S. aureus cells incubated with DL4CAR-6, DL5CAR-6, DLpCAR-6, and DLoCAR-6 showed changes indistinguishable from each other and from those observed with DL412 (Figure 3 and Figure 4). Cells of all samples demonstrated significant damage to the ultrastructure of the cell wall, the presence of inclusions; the cytoplasm became homogeneous, visible ribosomes were not observed, and the ultrastructure of the nucleoid changed (Figure 4).
Under the influence of all the above compounds, the nucleoid of S. aureus cells was fragmented and, in some cells, could touch the cytoplasmic membrane. DNA strands had an average electron density (Figure 4E–H), and the pattern of changes completely corresponded to that observed under treatment of S. aureus with DL412 (Figure 3). In dividing cells, a curvature of the division septum was observed.
The results obtained indicate that all carvacrol-containing compounds tested in this study, regardless of the structure of the central linker, effectively damaged S. aureus cells and demonstrated a multitarget effect. All compounds caused complete ribosome disorganization and changes in the nucleoid structure in S. aureus cells.

2.4. E. faecalis Ultrastructure Alteration by DL4CAR-6

The DL4CAR-6 compound significantly altered the ultrastructure of all E. faecalis cells, with the exception of the cell wall. In most cells (95%), the cytoplasmic membrane was visible throughout the entire cell wall (Figure 5A,C), whereas in intact cells, it was seen only in small areas. Membrane-associated inclusions gradually penetrated into the cytoplasm and increased in size. Electron-dense particles of irregular shape (15–22 nm) appeared in the cytoplasm (Figure 5A–C), which, judging by their size, could be the result of ribosome aggregation. The cytoplasmic layer around the nucleoid disappeared, and the peripheral layer containing ribosomes spread to the borders of the nucleoid.
The nucleoid in E. faecalis cells was severely damaged, the bundles of DNA strands were disrupted, and some strands were replaced by granular, electron-dense material (Figure 5A–C).
Images of E. faecalis cells treated with DL4CAR-6 were different from those of the bacterium in control and DL412-treated samples. Cells looked unusually dense, the cytoplasm was densely filled with electron-dense granules, and we designated such cells as “dense”.
A small number of E. faecalis cells (5%) incubated with DL4CAR-6 underwent changes similar to those observed in cells exposed to DL412. The inclusions appeared in the cells, the cytoplasm became homogeneous and had average electron density, ribosomes were not visible and DNA strands became more distinct.

2.5. E. faecalis Ultrastructure Alteration by DL5CAR-6

Compound DL5CAR-6 differed from DL4CAR-6 by only one additional methylene group in the central linker, and this small feature caused significant differences in the compound’s effect on E. faecalis cell ultrastructure.
Incubation of E. faecalis cells with the DL5CAR-6 compound altered the ultrastructure of all cells, but in different ways. In most of the cells (95%) incubated with compound DL5CAR-6, the cytoplasmic membrane became more visible, and membrane-associated inclusions appeared (Figure 5F). The cytoplasm had average electron density and looked homogeneous; the layer surrounding the nucleoid was absent. This state of cytoplasm allowed us to see ribosome uniform distribution throughout the cytoplasm (Figure 5D–F). The ribosomes did not form electron-dense aggregations, as in the case of DL4CAR-6. Compared to the “dark” cells described above, these cells looked much “lighter”, and from now on, we will designate them as “light”. The nucleoid contained granular material of average electron density, in which DNA strands were poorly visible; the bundles were absent (Figure 5D–F).
The changes in the remaining 5% of E. faecalis cells incubated with DL5CAR-6 were similar to the changes observed in cells incubated with the DL4CAR-6 compound: cells had a “dark” cell phenotype.

2.6. E. faecalis Ultrastructure Alteration by DLpCAR-6

Incubation of E. faecalis cells with the DLpCAR-6 compound differently affected the cells. The ultrastructure of 70% of cells (Figure 5G–I) was very similar to that described above in the “light” cells under the influence of the DL5CAR-6 compound.
The cytoplasmic membrane was hardly visible, intermediate layer was prominent. Inclusions associated with the membrane appeared in the cells, the cytoplasm had average electron density and looked homogeneous, the ribosomes were clearly visible and were evenly distributed throughout the cytoplasm (Figure 5G–I). The ribosomes did not form electron-dense aggregations, as in the case of DL4CAR-6. The nucleoid was severely affected; it was composed of an amorphous substance of the average electron density, in which DNA strands were hardly visible (Figure 5G–I).
The morphology of remaining E. faecalis cells (30%) was similar to the “dark” cells observed after incubation with the DL4CAR-6 compound: membrane-associated inclusions were observed in the cells, ribosome aggregates were detected in the cytoplasm, and the structure of DNA strand bundles was altered.

2.7. E. faecalis Ultrastructure Alteration by DLoCAR-6

Incubation of E. faecalis cells with DLoCAR-6, as with other carvacrol-containing compounds, affected the ultrastructure of all cells differently. The majority of the cells (80%) corresponded to “dark” cells in morphology (Figure 5J–L): contained inclusions, ribosome aggregates were located in the cytoplasm, and damage to the structure of DNA strand bundles was observed in the nucleoid (Figure 5J–L). The remaining cells (20%) of the sample were “light,” similar to those observed during incubation with DL5CAR-6 and DLpCAR-6.

3. Discussion

The development of multitarget drugs that attack several targets in bacterial cells is considered one of the promising approaches to combating bacteria with multiple antibiotic resistance [26,27]. Such compounds can be obtained by synthesizing molecules that combine groups with already known antibacterial activity [27,28].
In this work, we studied the effect of hybrids of carvacrol (a monoterpene with antibacterial activity [17]) and DL412, a compound we previously synthesized that exhibits multitarget activity and high antimicrobial efficacy against various bacteria in vitro [11].
Using TEM, we demonstrated that the pronounced destructive effect of DL412 is primarily due to damage to the protein-synthesizing apparatus of Gram-positive and Gram-negative bacteria [13,14].
The aim of this work was to study the ultrastructure of S. aureus and E. faecalis cells exposed to DL412-carvacrol hybrids (Figure 1). The chemical synthesis and characteristics of hybrids are presented in the Supplementary File. Each hybrid molecule included two carvacrol molecules that replaced the hydrophobic tails of DL412; the molecules differed in the structure of the central linker.
(1)
DL4CAR-6: the central linker was identical to DL412 (tetramethylene);
(2)
DL5CAR-6: the central linker was longer (pentamethylene);
(3)
DLoCAR-6: a benzene group formed the central linker (aromatic linker replaced the aliphatic one);
(4)
DLpCAR-6: the central linker was formed by a p-xylene molecule (aromatic).
All four hybrid compounds caused damage to the ultrastructure in S. aureus and E. faecalis cells; however, the ultrastructural manifestations of the effects varied both between bacterial species and between the compounds. Interspecies differences were undoubtedly related to differences in the morphology of intact bacteria (Figure 2), which reflected the features of their molecular organization.
To our knowledge, no studies have been published on the relationship between the ultrastructure and molecular organization of bacteria, so we are unable to include the results of other authors in the discussion of the results obtained in this work.
All carvacrol-containing compounds introduced into the culture medium with Gram-positive bacteria came into contact with the cell wall. This contact resulted in disorganization of the wall structure for S. aureus cells (Figure 2 and Figure 3), whereas the cell wall of E. faecalis retained the structure observed in intact cells (Figure 2 and Figure 3). It should be noted that the destruction of the S. aureus cell wall and the stability of the E. faecalis wall were observed during incubation of bacteria with all the compounds used. The changes occurring inside the cells allow us to conclude that the cell wall of both bacterial species was not a barrier for DL412 and all its derivatives.
The cell wall of E. faecalis apparently has pores suitable for the migration of all five compounds, allowing them to move into the cell. The cell wall of S. aureus, which has a different molecular composition [29], becomes disorganized and loosened, forming “pathways” for the penetration of compounds. We believe that this effect may be due to the structure of the S. aureus cell wall, which contains pentapeptide glycine cross-links in the structure of cell wall murein, in contrast to the more complex and diverse cross-links in the murein composition of the cell walls of other bacteria [29,30]. Severe damage to the cell wall of S. aureus by cationic amphiphiles may be critical for its viability: the MIC values for all cationic amphiphiles for this bacterium are incomparably lower than for E. faecalis (Table 1).
Exposure to the compound DL412 resulted in ribosome disorganization, and the cytoplasm of S. aureus and E. faecalis cells appeared homogeneous and less electron-dense (Figure 3). We observed a similar effect in Salmonella Gram-negative cells [14] and S. aureus cells when studying the DL412-ciprofloxacin hybrid [13]. Interestingly, when incubated with DL412, S. aureus ribosomes “disintegrated,” while E. faecalis ribosomes deformed and clumped together (Figure 3).
Compound DL412 exhibited RNAase activity in vitro, which was discovered shortly after its synthesis [9]. This activity logically explains the compound effect on bacterial ribosomes, and we use this hypothesis to analyze our results. RNAase activity was fully manifested in the DL4CAR-6 compound, while in other carvacrol-bearing compounds, its manifestations were similar to those of DL412 in S. aureus, but significantly reduced in E. faecalis cells.
Replacement of the hydrophobic “tails” of DL412 with carvacrol while maintaining the tetramethylene central linker (compound DL4CAR-6) led to ribosome aggregation and the formation of electron-dense particles in E. faecalis cells. In S. aureus cells, exposure to DL4CAR-6 resulted in complete ribosome disorganization, as did DL412. Complete ribosome disorganization in S. aureus cells also occurred upon exposure to all compounds containing carvacrol.
Increasing the length of the central linker by one methylene group (compound DL5CAR-6) did not cause changes in the integrity of ribosomes in E. faecalis cells; however, it altered their distribution in the cell: ribosomes were evenly distributed in the cytoplasm, not concentrated at the periphery, as in intact cells. Replacing the central methylene linker with aromatic ones (DLoCAR-6 and DLpCAR-6) resulted in the same change in ribosome localization in E. faecalis cells. It is likely that intact E. faecalis cells possess mechanisms that ensure the concentration of ribosomes in the cell’s periphery, and the compounds DL5CAR-6, DLoCAR-6, and DLpCAR-6 disrupt the functioning of these mechanisms.
Changes in nucleoid morphology were a striking change in the cell structure of S. aureus and E. faecalis under the influence of DL412 and its carvacrol-modified derivatives. In this work, we used the fixation of bacteria with the Ryter–Kellenberger method [31], which ensures fixation of the nucleoid in accordance with modern concepts: DNA is immersed in a “filling” substance that maintains its structure and functions. The substance contains many different types of RNA [31], which could be a target for the RNAse activity of the compounds studied.
TEM of ultrathin sections is not the best method for studying the nucleoid, but we nevertheless identified several changes in its structure as far as possible. When exposed to DL412, the nucleoids of S. aureus and E. faecalis bacteria changed shape, the DNA strands became thicker and straighter, and the electron density of the “filling” substance decreased. When incubated with all carvacrol-containing compounds, nucleoid fragmentation was observed in all S. aureus cells, and the DNA strands became less distinct.
On the contrary, in E. faecalis cells, when incubated with DL412, the nucleoid became rounded and acquired a clear boundary. The structure of the “filling” substance became granular, possibly due to the appearance of “grains” associated with the disorganization of DNA strands. The described nucleoid changes persisted when exposed to all carvacrol-containing compounds; however, the extent of the changes varied significantly.
Compound DL5CAR-6 induced less pronounced changes in E. faecalis cells than DL4CAR-6, which could be related to the addition of one methylene group to the central linker. All E. faecalis cells exhibited destructive changes in varying morphology when exposed to compounds containing a central aromatic linker. The cells were divided into two large groups based on the nature of their ultrastructural changes (“dark” and “light” cells). We believe these differences may be due to the stage of the bacterial life cycle.
Our results showed that replacing two hydrophobic tails in compound DL412 with two carvacrol molecules, while maintaining the tetramethylene linker, did not affect the nature and level of damage to S. aureus and E. faecalis cells, and the changes were the greatest among carvacrol-containing compounds.
Studies of the effects of other compounds have convincingly demonstrated (using E. faecalis as an example) that the structure of the central linker in cationic amphiphiles plays an important role in the development of cell damage detected at the ultrastructural level. Even a small increase in the length of the aliphatic linker in the DL5CAR-6 compound significantly altered the pattern of cell damage. The replacement of the tetramethylene linker with aromatic ones not only affected the pattern and level of cell damage but also revealed the heterogeneity of the E. faecalis cell population in terms of the character of cells’ ultrastructural changes.
The results of our study confirm the informative and effective use of transmission electron microscopy of ultrathin sections for studying bacteria and their changes during incubation with various antibiotics. This method allows, in particular, for the direct determination of the multitarget properties of developed compounds and their cellular targets. The results we obtained will undoubtedly be useful to developers of multitarget antibacterial compounds.

4. Materials and Methods

4.1. Antibacterial Compounds

The following compounds were used in the work: DL412, where D is DABCO (1,4-diazabicyclo [2.2.2]octane), L4 is tetramethylene linker, 12 is a dodecyl residue, and its conjugates with two carvacrol molecules—DL4CAR-6, DL5CAR-6, DLoCAR-6 and DLpCAR-6 (Figure 1)—where CAR is carvacrol, L5 is pentamethylene linker, Lp is 1,4-bis(methyl)benzene, Lo is 1,2-bis(methyl)benzene, 6 is a pentamethylene residue (Figure 1C).
The compound DL412 was first synthesized in the Laboratory of Organic Synthesis of the Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences (Novosibirsk, Russia) [11,12]. The design and synthesis of carvacrol-containing compounds was carried out for the first time at the above-mentioned laboratory and is presented in Supplementary File S1, and 1H and 13C NMR Spectra of the synthesized carvacrol-containing compounds are presented in Supplementary File S2. Stock solutions of ABCs were prepared in dimethyl sulfoxide (DMSO) (Serva, Heidelberg, Germany) at a concentration of 20 mM and diluted with Mueller-Hinton broth (MHB, Thermo Fisher Scientific, Waltham, MA, USA) for incubation with bacteria. We used all ABCs at a concentration of 100 µM (0.01 mM), as in previous studies [14].

4.2. Microorganisms and Their Incubation with ABCs

The work used bacteria strains obtained from the Collection of Extremophilic Microorganisms and Type Cultures of the Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the Russian Academy of Sciences (Novosibirsk, Russia): Gram-positive bacteria Staphylococcus aureus ATCC 25923 and Enterococcus faecalis ATCC 51299.
Both bacterial strains were grown on Luria–Bertani agar medium (LB, Difco Laboratories, Baltimore, MD, USA), then inoculated into MHB broth and cultured overnight in a shaker-incubator at 37 °C and 180 rpm (ES-20, SIA Biosan, Riga, Latvia). To prepare the samples for TEM, the bacterial cell concentration was adjusted with MHB to 1 × 107 CFU/mL (OD595 = 0.5). Optical density (OD) was determined using a densitometer DEN-1 (Biosan, Riga, Latvia). The resulting suspension (25 mL) was added to 50 mL plastic tubes, followed by 25 mL of a solution of one of the ABCs in MHB. The final ABC concentration was 100 µM (0.01 mM). Samples were incubated at 37 °C and 180 rpm (ES-20, SIA Biosan, Riga, Latvia) for exactly 15 min. Intact bacterial suspensions were used as a control. After incubation with ABCs, 500 μL of 25% glutaraldehyde solution (SPI supplies, West Chester, PA, USA) was added to the bacterial suspensions to stop the interaction of ABCs with bacterial cells.

4.3. Determination of Minimum Inhibitory Concentrations (MICs)

Antimicrobial susceptibility testing was performed using the broth microdilution method in 96-well plates (TPP, Trasadingen, Switzerland), according to the guidelines of the European Committee on Antimicrobial Susceptibility Testing (EUCAST) [32]. A culture grown on LB agar (BD, Franklin Lakes, NJ, USA) was inoculated into MHB and incubated overnight. Stock solutions of the compounds in DMSO were prepared at a concentration of 20 mM. The final cell concentration of the overnight broth cultures was adjusted in MHB to approximately 5 × 105 CFU/mL (OD595 = 0.1). Bacterial growth was assessed after 24 h by measuring the optical density at 595 nm for each well using a microplate reader (Uniplan, PICON, Moscow, Russia). MIC values were defined as the lowest compound concentration that completely inhibited visible bacterial growth. All experiments were performed in triplicate, and the highest MIC value among the three replicates was selected for further analysis. MIC values are given in Table 1.

4.4. Samples Processing for TEM Study

The bacterial suspensions (50 mL) containing 500 μL of 25% glutaraldehyde solution were centrifuged at 8600× g for 10 min (2-16PK, SIGMA Laborzentrifugen GmbH, Osterode am Harz, Germany), and the supernatant was removed. The pellets were transferred to 2 mL plastic tubes and fixed using a modified Ryter–Kellenberger method [31] in 1.5 mL of 1% OsO4 in 0.2 M citrate buffer, pH 6.0, and left overnight at room temperature. Then the pellets were washed with citrate buffer, and 1 mL aqueous solution of uranyl acetate (0.5%, pH 3.0) was added; the mixture was incubated for 2 h.
Fixed samples were dehydrated in solutions of ethanol and acetone of increasing concentration and embedded in an Epon-Araldite mixture (EMS, Hatfield, PA, USA), forming two blocks from each sample. A series of ultrathin sections were prepared on a Leica EM UC7 ultramicrotome (Leica, Wetzlar, Germany), using a diamond knife (Diatome, Nidau, Switzerland). The ultrathin sections were contrasted with lead citrate and uranyl acetate (both from EMS, Hatfield, PA, USA) solutions and examined in a Jem 1400 TEM (JEOL, Tokyo, Japan) at an accelerating voltage of 80 kV. Digital images were obtained using a Veleta side-entry TEM camera (EM SIS, Muenster, Germany). The measurements were made using the iTEM software version 5.2 (EM SIS, Muenster, Germany).

4.5. Ultrastructure Analysis of Damaged Cells

For TEM studies, 20–25 ultrathin sections were prepared from each block. Each ultrathin section contained approximately 1000 bacterial cell fragments, through which the section passed randomly. We analyzed only those cell fragments that the section passed through near the equator. To obtain a clear image, it is important that the section be perpendicular to the cells. If the section plane is tilted, the linear structure of the membranes is not visible, and the ribosomes become “blurred”. These features of electron microscopy necessitate viewing a large number of cells to select those suitable for analysis. We analyzed at least 200 matched bacterial cell sections for each chemical compound.
To determine the proportion of damaged cells, direct counting was performed on ultrathin sections on a TEM screen. At 6000–8000× magnification, grid units completely filled with bacteria were selected. Then, at a magnification of 20,000–30,000×, cross-sections of 100 S. aureus or E. faecalis cells were selected and counted. The percentage of cells with destructive changes was determined for compounds that led to different changes in bacteria. (data are presented in the relevant section).

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ijms27052217/s1.

Author Contributions

Conceptualization, E.I.R.; methodology, A.V.T., D.A.Z. and A.V.B.; validation, A.V.B. and L.S.K.; formal analysis, L.S.K.; investigation, E.S.R., A.E.G., A.V.B., A.V.T. and D.A.Z.; resources, E.I.R.; writing—original draft preparation, E.S.R.; writing—review and editing, E.I.R.; visualization, E.S.R. and A.E.G.; supervision, E.I.R.; project administration, E.I.R.; funding acquisition, E.I.R. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Russian state-funded project for ICBFM SB RAS (grant number 125012300656-5).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The original contributions presented in this study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding author(s).

Acknowledgments

We thank Vladimir N. Silnikov for discussion of the article and helpful comments.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Qiao, W.; Wang, L.; Luo, Y.; Yang, T. Synthetic approaches and therapeutic applications of FDA-approved antibacterial agents: A comprehensive review from 2003 to 2023. Eur. J. Med. Chem. 2025, 285, 117267. [Google Scholar] [CrossRef]
  2. Kaur, N.; Sahoo, J.; De, M. Development of Nanomaterials-Based Agents for Selective Antibacterial Activity. Chembiochem 2025, 26, e202400693. [Google Scholar] [CrossRef] [PubMed]
  3. World Health Organization. Antibacterial Agents in Clinical and Preclinical Development: An Overview and Analysis, 1st ed.; World Health Organization: Geneva, Switzerland, 2024. [Google Scholar]
  4. Heimann, D.; Kohnhauser, D.; Kohnhauser, A.J.; Bronstrup, M. Antibacterials with Novel Chemical Scaffolds in Clinical Development. Drugs 2025, 85, 293–323. [Google Scholar] [CrossRef] [PubMed]
  5. Oliveira Junior, N.G.; Souza, C.M.; Buccini, D.F.; Cardoso, M.H.; Franco, O.L. Antimicrobial peptides: Structure, functions and translational applications. Nat. Rev. Microbiol. 2025, 23, 687–700. [Google Scholar] [CrossRef]
  6. Del Olmo, M.L.; Andreu, C. Current Status of the Application of Antimicrobial Peptides and Their Conjugated Derivatives. Molecules 2025, 30, 3070. [Google Scholar] [CrossRef] [PubMed]
  7. Grigor’eva, A.; Bardasheva, A.; Tupitsyna, A.; Amirkhanov, N.; Tikunova, N.; Pyshnyi, D.; Ryabchikova, E. Changes in the Ultrastructure of Staphylococcus aureus Treated with Cationic Peptides and Chlorhexidine. Microorganisms 2020, 8, 1991. [Google Scholar] [CrossRef]
  8. Ghosh, C.; Haldar, J. Membrane-Active Small Molecules: Designs Inspired by Antimicrobial Peptides. ChemMedChem 2015, 10, 1606–1624. [Google Scholar] [CrossRef]
  9. Burakova, E.A.; Silnikov, V.N. Molecular design of artificial ribonucleases using electrostatic interaction. Nucleosides Nucleotides Nucleic Acids 2004, 23, 915–920. [Google Scholar] [CrossRef]
  10. Burakova, E.A.; Saranina, I.V.; Tikunova, N.V.; Sil’nikov, V.N. Tetracationic compounds based on 1,4-diazabicyclo[2.2.2]octane: Antibacterial activity and reactions with N-containing nucleophiles. Russ. Chem. Bull. 2015, 64, 1400–1405. [Google Scholar] [CrossRef]
  11. Burakova, E.A.; Saranina, I.V.; Tikunova, N.V.; Nazarkina, Z.K.; Laktionov, P.P.; Karpinskaya, L.A.; Anikin, V.B.; Zarubaev, V.V.; Silnikov, V.N. Biological evaluation of tetracationic compounds based on two 1,4-diazabicyclo[2.2.2]octane moieties connected by different linkers. Bioorg. Med. Chem. 2016, 24, 6012–6020. [Google Scholar] [CrossRef]
  12. Yarinich, L.A.; Burakova, E.A.; Zakharov, B.A.; Boldyreva, E.V.; Babkina, I.N.; Tikunova, N.V.; Silnikov, V.N. Synthesis and structure-activity relationship of novel 1,4-diazabicyclo[2.2.2]octane derivatives as potent antimicrobial agents. Eur. J. Med. Chem. 2015, 95, 563–573. [Google Scholar] [CrossRef] [PubMed]
  13. Grigor’eva, A.E.; Bardasheva, A.V.; Ryabova, E.S.; Tupitsyna, A.V.; Zadvornykh, D.A.; Koroleva, L.S.; Silnikov, V.N.; Tikunova, N.V.; Ryabchikova, E.I. Changes in the Ultrastructure of Staphylococcus aureus Cells Make It Possible to Identify and Analyze the Injuring Effects of Ciprofloxacin, Polycationic Amphiphile and Their Hybrid. Microorganisms 2023, 11, 2192. [Google Scholar] [CrossRef] [PubMed]
  14. Grigor’eva, A.E.; Tupitsyna, A.V.; Ryabova, E.S.; Bardasheva, A.V.; Zadvornykh, D.A.; Koroleva, L.S.; Silnikov, V.N.; Ryabchikova, E.I. Ribosome Disorganization and Other Effects of Artifitial RNAse DL412 on Salmonella enterica Cells. Appl. Biochem. Microbiol. 2025, 61, 228–237, Erratum in Appl. Biochem. Microbiol. 2025, 61, 1839. [Google Scholar] [CrossRef]
  15. Zadvornykh, D.; Zhang, Z.; Liu, C.; Serpokrylova, I.; Bardasheva, A.; Tikunova, N.; Silnikov, V.; Koroleva, L. Antibacterial activity of cationic amphiphil conjugates with ciprofloxacin. Int. J. Health Sci. 2022, 6, 3009–3023. [Google Scholar] [CrossRef]
  16. Ait-Ouazzou, A.; Espina, L.; Gelaw, T.K.; de Lamo-Castellvi, S.; Pagan, R.; Garcia-Gonzalo, D. New insights in mechanisms of bacterial inactivation by carvacrol. J. Appl. Microbiol. 2013, 114, 173–185. [Google Scholar] [CrossRef]
  17. Suntres, Z.E.; Coccimiglio, J.; Alipour, M. The bioactivity and toxicological actions of carvacrol. Crit. Rev. Food Sci. Nutr. 2015, 55, 304–318. [Google Scholar] [CrossRef]
  18. Latorre, R.; Valerii, M.C.; Benati, M.; Lewis, R.E.; Spigarelli, R.; Bernacchi, A.; Lippi, G.; Spisni, E.; Gaibani, P. Lights and Shadows of Essential Oil-Derived Compounds: Antimicrobial and Anti-Inflammatory Properties of Eugenol, Thymol, Cinnamaldehyde, and Carvacrol. Curr. Issues Mol. Biol. 2025, 47, 915. [Google Scholar] [CrossRef]
  19. Radocchia, G.; Giammarino, A.; Barberini, S.; Verdolini, L.; De Angelis, M.; Simonetti, G.; Pantanella, F.; Schippa, S.; Angiolella, L. Carvacrol and Thymol, a Synergistic Antimicrobial Activity Against Bacterial and Candida Species. Microbiologyopen 2025, 14, e70089. [Google Scholar] [CrossRef]
  20. Hyldgaard, M.; Mygind, T.; Meyer, R.L. Essential oils in food preservation: Mode of action, synergies, and interactions with food matrix components. Front. Microbiol. 2012, 3, 12. [Google Scholar] [CrossRef]
  21. Bouhdid, S.; Abrini, J.; Zhiri, A.; Espuny, M.J.; Manresa, A. Investigation of functional and morphological changes in Pseudomonas aeruginosa and Staphylococcus aureus cells induced by Origanum compactum essential oil. J. Appl. Microbiol. 2009, 106, 1558–1568. [Google Scholar] [CrossRef]
  22. Bouhdid, S.; Abrini, J.; Amensour, M.; Zhiri, A.; Espuny, M.J.; Manresa, A. Functional and ultrastructural changes in Pseudomonas aeruginosa and Staphylococcus aureus cells induced by Cinnamomum verum essential oil. J. Appl. Microbiol. 2010, 109, 1139–1149. [Google Scholar] [CrossRef] [PubMed]
  23. Boeder, A.M.; Spiller, F.; Carlstrom, M.; Izidio, G.S. Enterococcus faecalis: Implications for host health. World J. Microbiol. Biotechnol. 2024, 40, 190. [Google Scholar] [CrossRef] [PubMed]
  24. Wang, Y.; Xu, W.; Guo, S.; Xu, S.; Wang, J.; Zhang, S.; Kuang, Y.; Jin, P. Enterococci for human health: A friend or foe? Microb. Pathog. 2025, 201, 107381. [Google Scholar] [CrossRef] [PubMed]
  25. World Health Organization. WHO Bacterial Priority Pathogens List, 2024: Bacterial Pathogens of Public Health Importance to Guide Research, Development and Strategies to Prevent and Control Antimicrobial Resistance; World Health Organization: Geneva, Switzerland, 2024; p. 72. [Google Scholar]
  26. Feng, J.; Zheng, Y.; Ma, W.; Ihsan, A.; Hao, H.; Cheng, G.; Wang, X. Multitarget antibacterial drugs: An effective strategy to combat bacterial resistance. Pharmacol. Ther. 2023, 252, 108550. [Google Scholar] [CrossRef]
  27. Gray, D.A.; Wenzel, M. Multitarget Approaches Against Multiresistant Superbugs. ACS Infect. Dis. 2020, 6, 1346–1365. [Google Scholar] [CrossRef]
  28. Lungu, I.A.; Moldovan, O.L.; Biris, V.; Rusu, A. Fluoroquinolones Hybrid Molecules as Promising Antibacterial Agents in the Fight Against Antibacterial Resistance. Pharmaceutics 2022, 14, 1749. [Google Scholar] [CrossRef]
  29. Monteiro, J.M.; Covas, G.; Rausch, D.; Filipe, S.R.; Schneider, T.; Sahl, H.G.; Pinho, M.G. The pentaglycine bridges of Staphylococcus aureus peptidoglycan are essential for cell integrity. Sci. Rep. 2019, 9, 5010. [Google Scholar] [CrossRef]
  30. Schleifer, K.H.; Kandler, O. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol. Rev. 1972, 36, 407–477. [Google Scholar] [CrossRef]
  31. Kuzminov, A. Bacterial nucleoid is a riddle wrapped in a mystery inside an enigma. J. Bacteriol. 2024, 206, e0021123. [Google Scholar] [CrossRef]
  32. European Committee for Antimicrobial Susceptibility Testing of the European Society of Clinical Microbiology and Infectious Diseases. Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. Clin. Microbiol. Infect. 2003, 9, ix–xv. [Google Scholar] [CrossRef]
Figure 1. Chemical structure of compounds based on DABCO. (A)—cationic amphiphile DL412; (B)—general structure of the conjugate of the cationic amphiphile based on DABCO with the antibiotic ciprofloxacin; (C)—general structure of the conjugate of the cationic amphiphile based on DABCO with carvacrol. Chemical synthesis and characterization of cationic amphiphiles based on DABCO and carvacrol are presented in the Supplementary File.
Figure 1. Chemical structure of compounds based on DABCO. (A)—cationic amphiphile DL412; (B)—general structure of the conjugate of the cationic amphiphile based on DABCO with the antibiotic ciprofloxacin; (C)—general structure of the conjugate of the cationic amphiphile based on DABCO with carvacrol. Chemical synthesis and characterization of cationic amphiphiles based on DABCO and carvacrol are presented in the Supplementary File.
Ijms 27 02217 g001
Figure 2. Representative images of intact S. aureus (AC) and E. faecalis (DF) cells. 1—cytoplasm; 2—nucleoid. Black arrows indicate cell wall; white arrows—cytoplasmic membrane; black arrowheads point to intermediate layer; white arrowheads—to ribosomes; double-ended black arrow shows cytoplasmic zone without ribosomes; double-ended white arrow—cytoplasmic zone with ribosomes. Insets (C,F) show enlarged sections of the S. aureus and E. faecalis envelope. Length of scale bars corresponds to 100 nm. TEM, ultrathin sections.
Figure 2. Representative images of intact S. aureus (AC) and E. faecalis (DF) cells. 1—cytoplasm; 2—nucleoid. Black arrows indicate cell wall; white arrows—cytoplasmic membrane; black arrowheads point to intermediate layer; white arrowheads—to ribosomes; double-ended black arrow shows cytoplasmic zone without ribosomes; double-ended white arrow—cytoplasmic zone with ribosomes. Insets (C,F) show enlarged sections of the S. aureus and E. faecalis envelope. Length of scale bars corresponds to 100 nm. TEM, ultrathin sections.
Ijms 27 02217 g002
Figure 3. Representative images of S. aureus (AC) and E. faecalis (DJ) cells incubated with DL412 for 15 min. (GJ)—stages of inclusion formation in E. faecalis cells incubated with DL412 for 15 min. 1—cytoplasm; 2—nucleoid. Black arrows indicate cell wall; white arrows—cytoplasmic membrane; black arrowheads point to intermediate layer; white arrowheads—to ribosomes; double-ended white arrow—cytoplasmic zone with ribosomes; asterisks—inclusions. Insets (G,I,J) show enlarged sections of the E. faecalis inclusions. Length of scale bars corresponds to 100 nm. TEM, ultrathin sections.
Figure 3. Representative images of S. aureus (AC) and E. faecalis (DJ) cells incubated with DL412 for 15 min. (GJ)—stages of inclusion formation in E. faecalis cells incubated with DL412 for 15 min. 1—cytoplasm; 2—nucleoid. Black arrows indicate cell wall; white arrows—cytoplasmic membrane; black arrowheads point to intermediate layer; white arrowheads—to ribosomes; double-ended white arrow—cytoplasmic zone with ribosomes; asterisks—inclusions. Insets (G,I,J) show enlarged sections of the E. faecalis inclusions. Length of scale bars corresponds to 100 nm. TEM, ultrathin sections.
Ijms 27 02217 g003
Figure 4. Representative images of S. aureus cells incubated with carvacrol-containing compounds for 15 min. (A,E)—incubation with DL4CAR-6; (B,F)—incubation with DL5CAR-6; (C,G)—incubation with DLpCAR-6; (D,H)—incubation with DLoCAR-6; 1—cytoplasm; 2—nucleoid. Black arrows indicate cell wall; white arrows—cytoplasmic membrane; black arrowheads point to intermediate layer; asterisks—inclusions. Length of scale bars corresponds to 100 nm. TEM, ultrathin sections.
Figure 4. Representative images of S. aureus cells incubated with carvacrol-containing compounds for 15 min. (A,E)—incubation with DL4CAR-6; (B,F)—incubation with DL5CAR-6; (C,G)—incubation with DLpCAR-6; (D,H)—incubation with DLoCAR-6; 1—cytoplasm; 2—nucleoid. Black arrows indicate cell wall; white arrows—cytoplasmic membrane; black arrowheads point to intermediate layer; asterisks—inclusions. Length of scale bars corresponds to 100 nm. TEM, ultrathin sections.
Ijms 27 02217 g004
Figure 5. Representative images of cells E. faecalis incubated with carvacrol-containing compounds for 15 min. (AC)—incubation with DL4CAR-6; (DF)—incubation with DL5CAR-6; (GI)—incubation with DLpCAR-6; (JL)—incubation with DLoCAR-6. 1—cytoplasm; 2—nucleoid. Black arrows indicate cell wall; white arrows—cytoplasmic membrane; black arrowheads point to intermediate layer; white arrowheads—to ribosomes; double-ended white arrow—cytoplasmic zone with ribosomes; asterisks—inclusions. Insets (A,D,G,J) show enlarged sections of the E. faecalis cytoplasm with ribosomes. Insets (C,F,I,L) show enlarged sections of the E. faecalis envelope. Length of scale bars corresponds to 100 nm. TEM, ultrathin sections.
Figure 5. Representative images of cells E. faecalis incubated with carvacrol-containing compounds for 15 min. (AC)—incubation with DL4CAR-6; (DF)—incubation with DL5CAR-6; (GI)—incubation with DLpCAR-6; (JL)—incubation with DLoCAR-6. 1—cytoplasm; 2—nucleoid. Black arrows indicate cell wall; white arrows—cytoplasmic membrane; black arrowheads point to intermediate layer; white arrowheads—to ribosomes; double-ended white arrow—cytoplasmic zone with ribosomes; asterisks—inclusions. Insets (A,D,G,J) show enlarged sections of the E. faecalis cytoplasm with ribosomes. Insets (C,F,I,L) show enlarged sections of the E. faecalis envelope. Length of scale bars corresponds to 100 nm. TEM, ultrathin sections.
Ijms 27 02217 g005
Table 1. Minimum inhibitory concentration (MIC) values of the synthesized compounds.
Table 1. Minimum inhibitory concentration (MIC) values of the synthesized compounds.
CompoundsMIC (µM)
E. faecalisS. aureus
DL412634
DL4CAR-6634
DL5CAR-62508
DLoCAR-62508
DLpCAR-65008
Ciprofloxacin *4002
* Reference compound. DL412, where D is DABCO (1,4-diazabicyclo [2.2.2]octane), L4 is tetramethylene linker, 12 is a dodecyl residue, and its conjugates with two carvacrol molecules—DL4CAR-6, DL5CAR-6, DLoCAR-6 and DLpCAR-6 (Figure 1)—where CAR is carvacrol, L5 is pentamethylene linker, Lp is 1,4-bis(methyl)benzene, Lo is 1,2-bis(methyl)benzene, and 6 is a pentamethylene residue.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ryabova, E.S.; Grigor’eva, A.E.; Bardasheva, A.V.; Tupitsyna, A.V.; Zadvornykh, D.A.; Koroleva, L.S.; Ryabchikova, E.I. Ultrastructural Study of the Effects of Hybrid Compounds of Natural Monoterpene Carvacrol and Synthetic Cationic Amphiphile DL412 on S. aureus and E. faecalis Cells. Int. J. Mol. Sci. 2026, 27, 2217. https://doi.org/10.3390/ijms27052217

AMA Style

Ryabova ES, Grigor’eva AE, Bardasheva AV, Tupitsyna AV, Zadvornykh DA, Koroleva LS, Ryabchikova EI. Ultrastructural Study of the Effects of Hybrid Compounds of Natural Monoterpene Carvacrol and Synthetic Cationic Amphiphile DL412 on S. aureus and E. faecalis Cells. International Journal of Molecular Sciences. 2026; 27(5):2217. https://doi.org/10.3390/ijms27052217

Chicago/Turabian Style

Ryabova, Elena S., Alina E. Grigor’eva, Alevtina V. Bardasheva, Anastasiya V. Tupitsyna, Danila A. Zadvornykh, Lyudmila S. Koroleva, and Elena I. Ryabchikova. 2026. "Ultrastructural Study of the Effects of Hybrid Compounds of Natural Monoterpene Carvacrol and Synthetic Cationic Amphiphile DL412 on S. aureus and E. faecalis Cells" International Journal of Molecular Sciences 27, no. 5: 2217. https://doi.org/10.3390/ijms27052217

APA Style

Ryabova, E. S., Grigor’eva, A. E., Bardasheva, A. V., Tupitsyna, A. V., Zadvornykh, D. A., Koroleva, L. S., & Ryabchikova, E. I. (2026). Ultrastructural Study of the Effects of Hybrid Compounds of Natural Monoterpene Carvacrol and Synthetic Cationic Amphiphile DL412 on S. aureus and E. faecalis Cells. International Journal of Molecular Sciences, 27(5), 2217. https://doi.org/10.3390/ijms27052217

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop